Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study Of Xolair (Omaluzimab) In Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Anithistamine Treatment (H1) https://kusajili.fr:443/Trial/JFTWxBR9c0yagvwgwQ0Wcg%24a-phase-ii-multicenter-randomized-double-blind-placebo-controlled-dose-ranging-study-of-xolair-omaluzimab-in-patients-with-chro
I have read and accept the terms of use of the site and the Privacy Policy
Send your message